• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
All
Options & Futures
Funds
IPO Subscription
Structured Products
Investment Wiki
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List

Annovis Bio(ANVS.US)

Overview
News
Financials
© 2026 Longbridge|Disclaimer

Event Tracking

Dec3
Annovis Bio to Present Third-Stage Data on Parkinson's Dementia at Annual Meeting
13:01
Nov13
Annovis Bio released FY2025 9 Months Earnings on November 12 (EST), actual revenue USD 0, actual EPS USD -1.0099
04:00
Annovis Bio released FY2025 Q3 earnings on November 12 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -0.3699 (forecast USD -0.3766)
04:00
Nov7
Maxim Group Analyst Jason McCarthy Maintains Buy Rating on Annovis Bio
18:12
Oct14
Annovis Bio Inc. Issues Ordinary Shares to Raise $6 Million
21:20
Oct9
Annovis Bio Inc.'s Drug Buntanetap Shows Positive Biomarker Data in Alzheimer's Research
11:30

Schedules & Filings

Schedules
Filings
Nov12
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income -7.263 M, EPS -0.3699

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income -6.22 M, EPS -0.32

May13
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -5.537 M, EPS -0.32

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
ANPA
86.850
+258.88%
+62.650
NBY
19.160
+102.54%
+9.700
VLN
2.480
+58.97%
+0.920
GP
1.240
+51.04%
+0.419
ATGL
30.610
+46.96%
+9.781
OPAD
2.190
+44.08%
+0.670
VCIG
0.9601
+41.00%
+0.279
THH
29.470
+36.31%
+7.850
APLX
113.630
+35.44%
+29.730
ZNTL
3.740
+31.69%
+0.900
View More